Peek Behind the Paper: adherence and costs associated with ospemifene versus local estrogen in postmenopausal dyspareunia

In this feature, we Peek Behind the Paper with contributing study author Katharine Coyle (IQVIA, VA, USA) to further understand how real-world evidence (RWE) was employed to investigate the adherence and costs associated with ospemifene versus local estrogen in postmenopausal dyspareunia. Read the full research article in the Journal of Comparative Effectiveness Research now>> Please could you introduce yourself and your institution(s)? I am a Senior Consultant in Health Economics and Outcomes Research Real-World Insights at IQVIA (VA, USA). IQVIA is a US-based, multinational company serving the combined industries of health information technology and clinical research. This publication was a group effort...